Glucagon-like peptide-1 receptor agonists and pancreatitis: A reconcilable divorce
Cleveland Clinic Journal of Medicine · 2025
DOI: 10.3949/ccjm.92a.24113 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cleveland Clinic Journal of Medicine, 2025. Verfasst von Adi E Mehta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic, Cleveland, OH; Clinical Assistant Professor, Cleveland Clinic Lerner College…. Hauptthemen laut MEDLINE: Pancreatitis, Glucagon-Like Peptide-1 Receptor Agonists, Hypoglycemic Agents, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 18-mal zitiert (Crossref).
Abstract (Originalsprache)
Early clinical trials suggested that patients treated with glucagon-like peptide-1 (GLP-1) receptor agonists had a slightly increased risk of acute pancreatitis. Consequently, clinicians have avoided using GLP-1 receptor agonists in patients with a history of acute pancreatitis. However, recent large meta-analyses of clinical trial data do not support a class-wide risk. Denying these valuable therapeutic medications to patients with a history of pancreatitis seems unwarranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic, Cleveland, OH; Clinical Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH mehtaae…
- Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic, Cleveland, OH; Osteopathic Medical Student Year 1, Ohio University Heritage College of Osteopathic Medicine, Cleveland Campus, Cleveland, OH.
- Director, Diabetes Initiatives, Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic, Cleveland, OH; Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Clevelan…
Zitieren
APA
Mehta, A. E., Lomeli, L. D., & Pantalone, K. M. (2025). Glucagon-like peptide-1 receptor agonists and pancreatitis: A reconcilable divorce. Cleveland Clinic Journal of Medicine. https://doi.org/10.3949/ccjm.92a.24113
Vancouver
Mehta AE, Lomeli LD, Pantalone KM. Glucagon-like peptide-1 receptor agonists and pancreatitis: A reconcilable divorce. Cleveland Clinic Journal of Medicine. 2025. doi:10.3949/ccjm.92a.24113
BibTeX
@article{Mehta2025,
author = {Mehta, Adi E and Lomeli, Laura D and Pantalone, Kevin M},
title = {Glucagon-like peptide-1 receptor agonists and pancreatitis: A reconcilable divorce},
journal = {Cleveland Clinic Journal of Medicine},
year = {2025},
doi = {10.3949/ccjm.92a.24113}
}
EUVIMED